Long-term risks of Ozempic raise growing concerns

As World Obesity Day approaches, concerns grow over the long-term risks of weight-loss drugs like Ozempic. Many people, including those without serious health issues, are using these medications, raising questions about their safety and effectiveness. Patients often face challenges accessing semaglutide due to high costs and supply issues. When treatment is interrupted, many experience rapid weight regain, known as "Ozempic rebound." This pattern has been observed in various clinics and studies, highlighting the need for ongoing treatment. Research indicates that while some patients lose significant weight, others see little to no results. Experts are investigating the long-term effects of these drugs, especially for those using them for cosmetic reasons, as potential risks may outweigh benefits.